[1] GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet, 2017,390(10100):1211-1259. DOI: 10.1016/S0140-6736(17)32154-2.
[2] Pasricha SR, Tye-Din J, Muckenthaler MU, et al. Iron deficiency[J]. Lancet,2021,397(10270):233-248. DOI: 10.1016/S0140-6736(20)32594-0.
[3] DeLoughery TG. Safety of oral and intravenous iron[J]. Acta Haematol, 2019;142(1):8-12. DOI: 10.1159/000496966.
[4] 中国中西医结合学会血液学专业委员会. 缺铁性贫血(萎黄病)中西医诊疗专家共识[J]. 中国中西医结合杂志,2023,43(7):773-780. DOI:10.7661/j.cjim.20230505.073.
[5] Gong G, Zhou X, Huang D, et al. Danggui Buxue Tang: a review of its major components[J]. Altern Ther Health Med,2023,29(5):54-64.
[6] 张雨凝,李秀军. 李秀军教授中西医结合治疗缺铁性贫血的临床经验[J]. 中西医结合心血管病电子杂志,2019,7(3):149-151. DOI: 10.16282/j.cnki.cn11-9336/r.2019.03.113.
[7] 谢东杰,王爱迪,刘宝山. 当归补血汤在血液疾病中作用机制的研究进展[J]. 中华中医药杂志,2018,33(6):2488-2490.
[8] Huang GC, Chen SY, Tsai PW, et al. Effects of Dang-Gui-Bu-Xue-Tang, an herbal decoction, on iron uptake in iron-deficient anemia[J]. Drug Des Devel Ther, 2016, 10:949-957. DOI: 10.2147/DDDT.S94309.
[9] Liu Y, Ju Y, Qin X. Studies on the compatibility mechanism and material basis of Danggui Buxue Decoction against anemia mice using metabonomics and network pharmacology[J]. J Pharm Pharmacol,2021,73(6):767-777. DOI: 10.1093/jpp/rgab016.
[10] 齐利丽.当归补血汤对妊娠期缺铁性贫血模型大鼠骨髓巨噬细胞HO-1影响研究[D].咸阳:陕西中医药大学,2021. DOI:10.27294/d.cnki.gsxzc.2021.000047.
[11] Tie D, Fan Z, Chen D, et al. Mechanisms of Danggui Buxue Tang on hematopoiesis via multiple targets and multiple components: metabonomics combined with database mining technology[J]. Am J Chin Med,2022,50(4):1155-1171. DOI: 10.1142/S0192415X22500471.
[12] Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines[J]. J Cheminform, 2014, 6:13. DOI: 10.1186/1758-2946-6-13.
[13] Shi XQ, Yue SJ, Tang YP, et al. A network pharmacology approach to investigate the blood enriching mechanism of Danggui Buxue Decoction[J]. J Ethnopharmacol,2019,235:227-242. DOI: 10.1016/j.jep.2019.01.027.
[14] Gfeller D, Grosdidier A, Wirth M, et al. Swiss target prediction: a web server for target prediction of bioactive small molecules[J]. Nucleic Acids Res,2014,42(Web Server issue):W32-W38. DOI: 10.1093/nar/gku293.
[15] Crielaard BJ, Lammers T, Rivella S. Targeting iron metabolism in drug discovery and delivery[J]. Nat Rev Drug Discov, 2017, 16(6): 400-423. DOI: 10.1038/nrd.2016.248.
[16] Aisen P, Enns C, Wessling-Resnick M. Chemistry and biology of eukaryotic iron metabolism[J]. Int J Biochem Cell Biol, 2001, 33(10): 940-959. DOI: 10.1016/s1357-2725(01)00063-2.
[17] Hentze MW, Muckenthaler MU, Galy B, et al. Two to tango: regulation of mammalian iron metabolism[J]. Cell, 2010, 142(1): 24-38. DOI: 10.1016/j.cell.2010.06.028.
[18] Roemhild K, von Maltzahn F, Weiskirchen R, et al. Iron metabolism: pathophysiology and pharmacology[J]. Trends Pharmacol Sci,2021,42(8):640-656. DOI: 10.1016/j.tips.2021.05.001.
[19] 袁文贝,张雷虹. 基于网络药理学和分子对接法探讨消肿汤治疗痔病的作用机制[J]. 国际医药卫生导报,2024,30(21):3605-3613. DOI:10.3760/cma.j.issn.1007-1245.2024.21.017.
[20] Deng P, Li X, Wei Y, et al. The herbal decoction modified Danggui Buxue Tang attenuates immune-mediated bone marrow failure by regulating the differentiation of T lymphocytes in an immune-induced aplastic anemia mouse model[J]. PLoS One, 2017, 12(7): e180417. DOI: 10.1371/journal.pone.0180417.
[21] Wang J, Fang C, Wang S, et al. Danggui Buxue Tang ameliorates bleomycin-induced pulmonary fibrosis in rats through inhibiting transforming growth factor-beta1/Smad3/ plasminogen activator inhibitor-1 signaling pathway[J]. J Tradit Chin Med, 2020, 40(2): 236-244.
[22] Fleming RE. Hepcidin activation during inflammation: make it STAT[J]. Gastroenterology, 2007, 132(1): 447-449. DOI: 10.1053/j.gastro.2006.11.049.
[23] Zhang YZ, Xu F, Yi T, et al. Chemical profile analysis and comparison of two versions of the classic TCM formula Danggui Buxue Tang by HPLC-DAD-ESI-IT-TOF-MSn[J]. Molecules, 2014, 19(5):5650-5673. DOI: 10.3390/molecules19055650.
[24] Hämäläinen M, Nieminen R, Vuorela P, et al. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages[J]. Mediators Inflamm, 2007: 45673. DOI: 10.1155/2007/45673.
[25] Li Y, Yao J, Han C, et al. Quercetin, inflammation and immunity [J]. Nutrients. 2016, 8(3):167. DOI: 10.3390/nu8030167.
[26] Rauf A, Imran M, Khan IA, et al. Anticancer potential of quercetin: a comprehensive review[J]. Phytother Res, 2018, 32(11): 2109-2130. DOI: 10.1002/ptr.6155.
[27] Mazhar M, Kabir N, Simjee SU. Quercetin modulates iron homeostasis and iNOS expression of splenic macrophages in a rat model of iron deficiency anemia[J]. Chin J Nat Med, 2018, 16(8):580-589. DOI: 10.1016/S1875-5364(18)30095-5.
[28] Alam W, Khan H, Shah MA, et al. Kaempferol as a dietary anti-inflammatory agent: current therapeutic standing[J]. Molecules. 2020, 25(18):4073. DOI: 10.3390/molecules25184073.
[29] Chaudhary A, Jaswal VS, Choudhary S, et al. Ferulic acid: a promising therapeutic phytochemical and recent patents advances[J]. Recent Pat Inflamm Allergy Drug Discov, 2019,13(2):115-123. DOI: 10.2174/1872213X13666190621125048.
|